IM
Immunotech Laboratories, Inc.
IMMB · OTC
$0.00 +0.00% (+$0.00)
Market Cap ¥406.6K
P/E Ratio 0.00x
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
56 /100
Fair EV/EBITDA 14.92x
P/S 0.00x
P/B 0.00x
Growth
39 /100
Stable FCF growth 87.87%
Book val. growth 0.17%
Rev. growth 8.56%
Profitability
8 /100
Weak Net margin 1.15%
Op. margin 2.21%
Gross margin 3.15%
Quality
36 /100
Average ROA 1.76%
Asset turnover 1.54x
ROIC 3.51%
Debt
16 /100
High Current ratio 1.24x
Int. coverage 3.09x
Net debt/EBITDA 14.92x
Stability
40 /100
Moderate Rev. volatility 12.56%
EPS volatility 301.40%
Profitable years 1
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o IMMB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jennifer L. Bath
Employees
4
Headquarters
Monrovia